TB Vaccines
The Bacillus Calmette-Guérin (BCG) vaccine is the primary tuberculosis vaccine, providing protection against severe forms of the disease, especially in children. Treatment involves multi-drug regimens for 6 to 9 months, including first-line anti-TB agents like isoniazid, pyrazinamide, rifampin, ethambutol, and streptomycin.
TB vaccines aim to prevent tuberculosis infection or disease progression. Bacillus Calmette-Guérin (BCG) is the only licensed TB vaccine, primarily administered to infants in high-burden areas. While it protects against severe forms of childhood TB, its efficacy against adult pulmonary TB varies. Ongoing research focuses on developing novel TB vaccines with improved efficacy and durability. Strategies include subunit vaccines targeting specific TB antigens, viral vectors, and recombinant BCG strains. Clinical trials assess vaccine safety, immunogenicity, and efficacy, aiming to advance promising candidates towards licensure. Successful TB vaccination could significantly contribute to global TB control efforts, reducing disease burden and transmission.
Related Conference of TB Vaccines
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
TB Vaccines Conference Speakers
Recommended Sessions
- Asthma
- Atelectasis and Pneumothorax
- Cardiopulmonary Disease
- Chronic Obstructive Pulmonary Disease (COPD)
- Climate Change and Respiratory Diseases
- Epidemiology of TB Disease
- Gastroesophageal reflux disease (GERD)
- Latent TB Infection and Active TB Disease
- Lung Cancer: Screening, Diagnosis & Treatment
- Lung Function in Men with and without HIV
- Lung Infection
- Multidrug-resistant TB
- Mycobacterial Infections
- Palliative Care for Advanced Lung Cancer
- Pulmonary Complications of Endocrine Diseases
- Pulmonary Diseases and Therapeutics
- Pulmonary Edema
- TB Clinical Trials
- TB Diagnosis, Prevention & Treatment
- TB Vaccines
- TB-HIV Co-infections
- Zoonotic TB
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)